WisdomTree (WT) COO vests 350,395 PRSUs; 179,207 shares withheld

Rhea-AI Filing Summary

WisdomTree President and COO Jarrett Lilien reported the vesting and settlement of performance-based restricted stock units. On January 27, 2026, 350,395 PRSUs were converted into common shares at an exercise price of $0.0000, including 14,710 units from dividend reinvestment. Based on an independent report and compensation committee certification, the company’s relative total shareholder return ranked in the 84.62nd percentile, causing 199% of the target PRSUs to vest. Upon settlement, 179,207 shares were withheld to cover taxes, leaving Lilien with 1,170,245 directly held common shares, which include other restricted stock awards scheduled to vest through January 2029.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lilien R Jarrett

(Last) (First) (Middle)

C/O WISDOMTREE, INC.

250 WEST 34TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10119

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WisdomTree, Inc. [ WT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

3. Date of Earliest Transaction (Month/Day/Year)
01/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/27/2026		M		350,395(1)(2)	A	$0.0000	1,349,452(3)	D
Common Stock	01/27/2026		F		179,207(4)	D	$0.0000	1,170,245(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Based Restricted Stock Units	(5)	01/27/2026		M			350,395(1)(2)(5)	(5)	(5)	Common Stock	350,395(1)(2)(5)	$0.0000	0.0000	D

Explanation of Responses:

1. Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

2. Includes the reinvestment of dividend equivalents into 14,710 PRSUs between the grant date and vesting date.

3. Includes restricted stock awards vesting as to (i) 114,570 shares on January 25, 2027, (ii) 59,724 shares on January 25, 2028 and (iii) 23,785 shares on January 25, 2029.

4. Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

5. These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

	/s/ Marci Frankenthaler, Attorney-in-Fact	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did WisdomTree (WT) report for Jarrett Lilien?

WisdomTree reported that President and COO Jarrett Lilien settled 350,395 performance-based restricted stock units into common shares. The units vested based on a three-year relative total shareholder return performance test and were exercised at an effective price of $0.0000 per share.

How many WisdomTree PRSUs vested for Jarrett Lilien and why?

350,395 PRSUs vested for Jarrett Lilien after a three-year performance period. An independent specialist found WisdomTree’s relative total shareholder return at the 84.62nd percentile, leading the compensation committee to certify vesting at 199% of the previously reported target PRSU amount.

How many WisdomTree shares were withheld for taxes in this Form 4?

Upon PRSU vesting, 179,207 WisdomTree common shares were withheld to cover tax obligations. These shares came from the vested PRSUs and reduced the net number of shares delivered while leaving the reported transaction price per share at $0.0000.

How many WisdomTree shares does Jarrett Lilien own after the reported transactions?

After the January 27, 2026 transactions, Jarrett Lilien directly owns 1,170,245 WisdomTree common shares. This total includes restricted stock awards scheduled to vest in tranches on January 25, 2027, January 25, 2028, and January 25, 2029, as detailed in the filing.

What are the future vesting schedules for Jarrett Lilien’s restricted WisdomTree stock?

The filing states that restricted stock awards vest as to 114,570 shares on January 25, 2027, 59,724 shares on January 25, 2028, and 23,785 shares on January 25, 2029. These amounts are part of Lilien’s ongoing equity compensation package at WisdomTree.

How were dividend equivalents treated on Jarrett Lilien’s WisdomTree PRSUs?

Dividend equivalents on the PRSUs were reinvested into additional units during the performance period. The filing notes that 14,710 extra PRSUs resulted from dividend reinvestment between the original grant date and the final vesting date, increasing the total settled units.

What performance metric determined Jarrett Lilien’s PRSU vesting at WisdomTree?

Vesting was based on WisdomTree’s relative total shareholder return over three years versus a peer group. An independent valuation specialist reported performance at the 84.62nd percentile, and the compensation committee certified vesting at 199% of the target PRSU amount for Jarrett Lilien.